Efficacy and Safety of Two Anti-T-lymphocyte Immune Globulin (ATG-F) Induction Regimens in Anew Kidney Transplant Patients
Clinical trial NCT02267512 · COMPLETED
Trial details
- NCT number
- NCT02267512
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-31
- Primary completion
- 2015-12-31
- Enrollment
- 280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.